Biogen BIIB
NASDAQ BIIB
$222.82 -3.06 (-1.35%)
At close: Oct 1, 2026 · 4:00 PM EDT

Biogen (BIIB) Finished Goods (2010 - 2018)

Updated

Biogen's Finished Goods came in at $133.5 million for Q4 2018, down 15.2% from $157.4 million a year earlier.

Analysis

Biogen (BIIB) Finished Goods (2010 - 2018) Analysis & Trends

Going back to Q4 2010, Biogen's Finished Goods data covers 12 quarters.

  • Finished Goods carries a five-year compound annual growth rate of 4.2% (FY2013 to FY2018).
  • Going back by year, Finished Goods was $157.4 million in FY2017 (-7.6%), $170.3 million in FY2016 (+19.1%), $143 million in FY2015 (-12.9%) and $164.2 million in FY2014 (+51.2%).
  • The Q4 2018 figure represents the lowest quarterly Finished Goods since Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Biogen 33.37 Bn 20.03 Bn 1.96 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 133.50 Mn
Dec 31, 2017 157.40 Mn
Dec 31, 2016 170.30 Mn
Dec 31, 2015 143.00 Mn
Dec 31, 2014 164.20 Mn
Dec 31, 2013 108.60 Mn
Mar 31, 2013 120.70 Mn
Dec 31, 2012 100.70 Mn
Jun 30, 2012 103.20 Mn
Mar 31, 2012 83.30 Mn
Dec 31, 2011 73.60 Mn
Dec 31, 2010 230.10 Mn
API Access

Biogen Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=BIIB&period=max&api_key=YOUR_API_KEY